NLLSF(NLLSF)
NLLSF
No analyst ratings available
No analyst price targets available for NLLSF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $789M | $1.36B | $1.75B | $5.54B |
| Low | $678M | $1.00B | $1.37B | $4.33B |
| High | $941M | $1.68B | $2.14B | $6.77B |
| EBITDA Avg | $-410M | $-707M | $-912M | $-2.88B |
| Low | $-490M | $-876M | $-1.12B | $-3.53B |
| High | $-353M | $-522M | $-713M | $-2.25B |
| EBIT Avg | $-502M | $-864M | $-1.12B | $-3.52B |
| Low | $-598M | $-1.07B | $-1.36B | $-4.31B |
| High | $-432M | $-638M | $-872M | $-2.75B |
| Net Income Avg | $-609M | $-398M | $-276M | $95M |
| Low | $-785M | $-513M | $-355M | $68M |
| High | $-436M | $-285M | $-197M | $123M |
| EPS Avg | $-0.34 | $-0.22 | $-0.15 | $0.05 |
| Low | $-0.43 | $-0.28 | $-0.20 | $0.04 |
| High | $-0.24 | $-0.16 | $-0.11 | $0.07 |
| Analysts (Rev / EPS) | 7 / 1 | 10 / 1 | 4 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $209M | $243M | $247M | $392M | $173M | $178M |
| Low | $193M | $223M | $228M | $361M | $160M | $164M |
| High | $216M | $272M | $268M | $424M | $188M | $192M |
| EBITDA Avg | $-109M | $-126M | $-129M | $-204M | $-90M | $-92M |
| Low | $-113M | $-142M | $-139M | $-221M | $-98M | $-100M |
| High | $-101M | $-116M | $-118M | $-188M | $-83M | $-85M |
| EBIT Avg | $-133M | $-154M | $-157M | $-249M | $-110M | $-113M |
| Low | $-138M | $-173M | $-170M | $-270M | $-119M | $-122M |
| High | $-123M | $-142M | $-145M | $-230M | $-102M | $-104M |
| Net Income Avg | $-146M | $-243M | $-116M | $-97M | $-106M | $-93M |
| Low | $-161M | $-269M | $-129M | $-108M | $-117M | $-104M |
| High | $-131M | $-218M | $-105M | $-87M | $-95M | $-84M |
| EPS Avg | $-0.08 | $-0.13 | $-0.06 | $-0.05 | $-0.06 | $-0.05 |
| Low | $-0.09 | $-0.15 | $-0.07 | $-0.06 | $-0.06 | $-0.06 |
| High | $-0.07 | $-0.12 | $-0.06 | $-0.05 | $-0.05 | $-0.05 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |